EN
Patient-first cell therapy innovation
 
2023
  • 0
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
. 2023 Oct 5;9(11):e20708. doi: 10.1016/j.heliyon.2023.e20708
Du Z, Zhang T, Lin Y, Dong G, Li A, Wang Z, Zhang Y, Giamas G, Stebbing J, Zhu L, Peng L.

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma
. 2023 Oct 9;10:1749–1765. doi: 10.2147/JHC.S417407
Lin S, Cao Y, Zhu K, Yang C, Zhu X, Zhang H, Zhang R.
04.18
2025
Source:天科雅
Keysword:
Related Reading

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer